Quantabio is a biotechnology startup founded in 2001 and headquartered in the United States. The company specializes in the development and provision of advanced DNA and RNA amplification reagents for molecular testing applications in applied, translational, and life science research. With a focus on critical cloning, PCR, qPCR, and Next-Generation Sequencing (NGS) based applications, Quantabio leverages decades of experience in pioneering amplification technologies to deliver cutting-edge products to researchers.
There is no investment information
No recent news or press coverage available for Quantabio.